Overuse of drugs for ovarian stimulation questioned

Fertility experts have called for IVF clinics to limit the use of drugs to stimulate the production of eggs.

Written bySPIS MedWire
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Fertility experts have called for IVF clinics to limit the use of drugs to stimulate the production of eggs. In a study in the journal Human Reproduction, researchers emphasized the benefits of using the woman's natural cycle in most cases.

The team from the Assisted Conception Unit at King's College Hospital, London, reported that in 60 – 70% of cases, a series of treatment cycles without using ovarian stimulation would be safer, less stressful and result in fewer multiple births. They also point out that it would cost only a fifth of the price of current practices. The study involved 181 natural treatment cycles in 52 women. They were found to have the same chance of becoming pregnant after an average of three to four cycles of treatment as women undergoing conventional drug-stimulated treatment.

Geeta Nargund, who led the study, admitted that for women who don't ovulate or who have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA